Insider buying
~$10K5,102 sh @ $1.97
First insider buy since Oct 2024Traded Sep 22 · filed 2 days later
Since the trade −14.2% · S&P 500 −7.4% · to Nov 19
Bought 83% below the 52-week high, RSI 65, 62% under its 200-day average, 14 points ahead of the S&P 500 over 3 months
An Engene Therapeutics director paid $10K out of pocket for Engene Therapeutics shares.